Thomas F. Woolf
- Pharmacology top 0.5%
- Oncology top 10%
- Molecular Biology
- Pharmacology top 5%
- Pediatrics, Perinatology and Child Health top 10%
- Co-authors
- Kan HeRoger N. HayesPaul F. HollenbergMichael SinzNeal CastagnoliBabu SubramanyamWilliam F. PoolK. R. Krishna Iyer
- Topics
- Pharmacogenetics and Drug Metabolism (24 papers)Drug Transport and Resistance Mechanisms (12 papers)Cholinesterase and Neurodegenerative Diseases (6 papers)
- Cited by
- PharmacologyBiological Psychiatry
- Journals
- HepatologyBiochemical and Biophysical Research CommunicationsJournal of Medicinal Chemistry
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Thomas F. Woolf
43 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 97
- Pharmacology 685
- Oncology 389
- Molecular Biology 342
- Pharmacology 265
- Pediatrics, Perinatology and Child Health 165
Countries citing papers authored by Thomas F. Woolf
This map shows the geographic impact of Thomas F. Woolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Woolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Woolf more than expected).
Fields of papers citing papers by Thomas F. Woolf
This network shows the impact of papers produced by Thomas F. Woolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Woolf. The network helps show where Thomas F. Woolf may publish in the future.
Co-authorship network of co-authors of Thomas F. Woolf
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Woolf. A scholar is included among the top collaborators of Thomas F. Woolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Woolf. Thomas F. Woolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 26 | |
| 3 | 5 | |
| 4 | 78 | |
| 5 | 33 | |
| 6 | 71 | |
| 7 | 19 | |
| 8 | 8 | |
| 9 | 16 | |
| 10 | 2 | |
| 11 | 23 | |
| 12 | 30 | |
| 13 | 9 | |
| 14 | 3 | |
| 15 | 9 | |
| 16 | 4 | |
| 17 | 9 | |
| 18 | 5 | |
| 19 | 11 | |
| 20 | 55 |
About Thomas F. Woolf
Thomas F. Woolf is a scholar working on Pharmacology, Biochemistry and Pharmacology, having authored 44 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (24 papers), Drug Transport and Resistance Mechanisms (12 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). The work is most often cited by research in Pharmacology (685 citations), Pharmacology (265 citations) and Biological Psychiatry (38 citations). Thomas F. Woolf has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Kan He, Roger N. Hayes, Paul F. Hollenberg, Michael Sinz, Neal Castagnoli, Babu Subramanyam, William F. Pool, K. R. Krishna Iyer, Ann E. Black and James D. Adams. Their work appears in journals such as Hepatology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.